April 2017. Weekly business magazine Challenges features Acticor Biotech in its special report on the “Top 100 startups to invest in”.
Media Coverage
March 8, 2017
Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke
March 2017. La Gazette du Laboratoire publishes an article on Acticor Biotech: “Acticor Biotech, a key R&D deal after a successful funding round for the treatment in the acute phase of ischemic stroke.
June 30, 2016
Biotech Finances: “Twice rewarded Acticor to raise funds again”
June, 30th 2016. Biotech Finances publishes an article on Acticor Biotech: “Double lauréate, Acticor lève des fonds” (Twice rewarded Acticor to raise funds again). Download full text article (PDF, French)
April 1, 2016
Biotech Finances: “Acticor moves forward and comes back to crowdfunding!”
March, 14th 2016. Biotech Finances publishes an article on Acticor Biotech: “Acticor avance et retourne au crowdfunding !” (Acticor moves forward and comes back to crowdfunding).
February 23, 2015
BioPharmAnalyses.fr: French crowdfunding supports Acticor Biotech
Le crowdfunding français soutient Acticor Biotech By Anne Lise Berthier – Published on February 02, 2015 | No.93 Spécialisé dans le développement de nouveaux antithrombotiques pour le traitement de l’accident vasculaire cérébral, le français Acticor Biotech vient de finaliser une augmentation de capital de 0,59 million d’euros auprès de la plateforme de crowdfunding Anaxago et […]
February 7, 2015
Les Echos.fr: Crowdfunding: new platforms, new projects
Crowdfunding : nouvelles plates-formes, nouveaux projets By Marie-Christine Sonkin – Published on February 05, 2015 “[…] la plate-forme Anaxago , spécialiste du « private equity » et de l’immobilier, a permis à Acticor Biotech, spin-off de l’Inserm, de collecter plus de 500.000 euros. La société développe une stratégie thérapeutique innovante pour traiter en urgence les […]